The adjuvant effect of melanin is superior to Incomplete Freund adjuvant in a tumor subunit vaccine model

      Background: We recently reported that synthetic melanin bound to subunit vaccine antigens significantly enhances CD8+ T-cell responses in mice [1]. In an established tumor model, we compared this vaccine approach to the standard adjuvant formulation combining the Incomplete Freund Adjuvant (IFA) and a TLR9 agonist.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect